The Swiss pharmaceutical association Interpharma said this means that access to vital medicines is becoming increasingly difficult.
The benchmarking study conducted by the pharmaceutical industry and the Swiss Agency for Therapeutic Products, Swissmedic, reveals that companies are submitting their applications later in Switzerland compared to Europe, and that the duration of the review process has also increased, Interpharma announced on Wednesday.
More
More
What’s behind Switzerland’s push for drug-pricing secrecy?
This content was published on
The Swiss parliament is considering measures on drug pricing that are drawing the ire of some health experts.
On average, a drug is approved in Switzerland 249 days later than by the EMA, which represents a 48% increase compared to the previous year. Companies submitted their applications for authorisation to Swissmedic 244 days later than to the EMA.
Interpharma attributes this to the poor framework conditions in Switzerland, which have caused the Swiss market to receive progressively less priority.
Translated from German by DeepL/sp
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
The image of foreigners in Switzerland has deteriorated
This content was published on
The Federal Statistical Office has found that Swiss people’s views of foreigners have worsened over the last couple of years.
After mild winter, nature wakes up earlier in Switzerland
This content was published on
Once again this year, nature has woken up earlier than normal, between a week and ten days ahead of schedule due to a mild winter.
Computer failure disrupts air traffic at Geneva airport
This content was published on
A computer breakdown has disrupted operations at Geneva Airport since midday on Tuesday. Significant delays are expected.
Swiss show high willingness to pay for sustainable flats
This content was published on
Tenants in Switzerland are in favour of sustainable flats. However, the willingness to pay differs by income according to a new study.
Swiss customs intercepted over 200 tonnes of smuggled meat in 2024
This content was published on
The Federal Office for Customs and Border Security intercepted around 208 tonnes of smuggled meat at border crossings in 2024.
Switzerland faces infrastructure gaps for CO2 capture
This content was published on
Switzerland must actively remove CO2 from the air in order to become climate-neutral by 2050. However, the infrastructure for this isn't sufficient.
Swiss parliament prohibits sale of Swiss space company Beyond Gravity
This content was published on
The Swiss parliament has said that the Swiss government should not sell the Swiss space company Beyond Gravity, which is part of RUAG.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Secret discounts leave patients at drugmakers’ mercy
This content was published on
A University of Zurich study has found that using confidential discounts on drugs does little to make them available faster and more affordable.
How drug prices are negotiated in Switzerland and beyond
This content was published on
Switzerland's pharmaceutical sector supplies drugs worldwide, but not all countries receive them with the same price tag. Here's why.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.